| abstract |
The present invention relates to a pharmaceutical aqueous suspension formulation for parenteral administration having a substantially stabilized pH, which comprises a biologically active compound and an effective concentration of pH control of L-methionine. Preferably, the biologically active compound is a steroidal compound, for example, exemestane, medroxyprogesterone acetate and estradiol cypionate or a combination of medroxyprogesterone acetate and estradiol cypionate. |